Unchanged efficacy of a pertussis toxoid vaccine throughout the two years after the third vaccination of infants

Pediatric Infectious Disease Journal

Volumn 16, Issue 2, 1997, Pages 180-184

  Taranger, John ^a,c   Trollfors, Birger ^a   Lagergård, Teresa ^a   Lind, Lena ^a   Sundh, Valter ^a   Zackrisson, Gunilla ^a   Bryla, Dolores A ^b   Robbins, John B ^b  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^c Göteborg Pertussis Vacc Trial ^*  (Sweden)

Author keywords

efficacy; Pertussis; vaccine

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; DIPHTHERIA TETANUS TOXOID; PERTUSSIS VACCINE;

ANTIBODY RESPONSE; ARTICLE; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; MAJOR CLINICAL STUDY; PERTUSSIS; PRIORITY JOURNAL; VACCINATION;

ANTIBODIES, BACTERIAL; BORDETELLA PERTUSSIS; CHILD, PRESCHOOL; COHORT STUDIES; DIPHTHERIA TOXOID; DIPHTHERIA-TETANUS VACCINE; DIPHTHERIA-TETANUS-PERTUSSIS VACCINE; FOLLOW-UP STUDIES; HUMANS; IMMUNIZATION SCHEDULE; INFANT; NASOPHARYNX; POLYMERASE CHAIN REACTION; RANDOMIZED CONTROLLED TRIALS; TETANUS TOXOID; TOXOIDS; VACCINATION; VACCINES, COMBINED;

EID: 0031042102     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-199702000-00003     Document Type: Article

References (14)

1. Trollfors B, Taranger J, Lagergård T, et al. A placebo-controlled trial of a pertussis toxoid vaccine. N Engl J Med 1995;333:1045-50.
2. Gustafsson L, Hallander HO, Olin P, Reizenstein E, Storsaeter J. A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine. N Engl J Med 1996;334:349-55.
3. Greco D, Salmaso S, Mastrantonio P, et al. A controlled trial of two acellular and one whole-cell vaccine against pertussis. N Engl J Med 1996;334:341-8.
4. Isacson J, Trollfors B, Taranger J, Zackrisson G, Lagergård T. How common is whooping cough in a nonvaccinating country? Pediatr Infect Dis J 1993;12:284-8.
5. Mark A, Granström M. Cumulative incidence of pertussis in an unvaccinated preschool cohort based on notifications, interview and serology. Eur J Epidemiol 1991;7:121-6.
6. Taranger J, Trollfors B, Lagergård T. Clinical trials of a monocomponent pertussis toxoid vaccine (NICHD Ptxd): a technical report. The Göteborg Pertussis Vaccine Study, Göteborg University. Göteborg, Sweden: Graphic Systems, 1995.
7. WHO meeting on case definition of pertussis, Geneva, January 10 to 11, 1991. MIN/EPI/PERT/91.1. Geneva: World Health Organization, 1991.
8. Taranger J, Trollfors B, Lagergård T, Zackrisson G. Parapertussis infection followed by pertussis infection. Lancet 1994; 344:1703.
9. Clopper CJ, Pearson ES. The use of confidence or fiducial limits illustrated in the case of the binomial. Biometrika 1934;26:404-13.
10. Breslow NE, Day NE. Statistical methods in cancer research. vol II. Lyon, France: International Agency for Research on Cancer, 1987.
11. Gart JJ, Nam J. Approximate interval estimation of the ratio of binomial parameters: a review and corrections for skewness. Biometrics 1988;44:323-38.
12. Trollfors B, Taranger J, Lagergård T, et al. Efficacy of a monocomponent pertussis toxoid vaccine after household exposure to pertussis. J Pediatr (in press).
13. Hallander HO, Storsaeter J, Möllby R. Evaluation of serology and nasopharyngeal cultures for diagnosis of pertussis in a vaccine efficacy trial. J Infect Dis 1991;163:1046-54.
14. Edwards KM, Decker MD. Acellular pertussis vaccines for infants. N Engl J Med 1996;334:391-2.